Health Catalyst, Inc.
HCAT- Exchange
- Nasdaq
- Industry
- Services-Computer Programming, Data Processing, Etc.
- SEC CIK
- 0001636422
In the last 90 days, Health Catalyst, Inc. insiders filed 1 open-market purchase and 0 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $104.0M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 12, 2026
- $103.6M
- Insider buysLast 90 days, $105.4K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 128
- 13F valueReported value at the end of Q2 2026
- $104.0M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $311.1M
- +1.5% year over year
- Net income, FY2025
- -$178.0M
- No comparable prior period
- Free cash flow, FY2025
- -$237.0K
- −101.8% year over year
- Revenue, Q3 FY2026
- $56.3M
- −26.3% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $178.0M (57.2% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.95M
- Shares sold short
- Change
- −115.0K
- −5.6% vs. previous
- Days to cover
- 7.18
- At average daily volume
Superinvestors holding HCAT, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding HCAT at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Health Catalyst, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 (view filing)4:52 PM ET | Sep 14 | 2 days | Kohl SimeonChief Executive Officer | PPurchase | +59.0K | $1.79 | +$105.4K | +2.1%2.86M after | |
| Dec 9, 2025 (view filing) | Dec 5 | 4 days | Landry BenjaminGeneral Counsel | SSale | −27.4K | $2.64 | −$72.4K | −21.5%100.0K after | 10b5-1 |
| Dec 9, 2025 (view filing) | Dec 4 | 5 daysLate | Larson-Green JulieDirector | SSale | −48.0K | $2.67 | −$128.2K | −39.5%73.6K after | |
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | Landry BenjaminGeneral Counsel | SSale | −6.17K | $3.35 | −$20.7K | −4.2%141.8K after | 10b5-1 |
| Jun 9, 2025 (view filing) | Jun 5 | 4 days | Landry BenjaminGeneral Counsel | SSale | −6.06K | $3.94 | −$23.9K | −3.9%151.1K after | 10b5-1 |
| May 7, 2025 (view filing) | May 5 | 2 days | LeSueur DanielChief Operating Officer | SSale | −5.21K | $4.10 | −$21.4K | −2.5%205.8K after | 10b5-1 |
| Apr 7, 2025 (view filing) | Apr 3 | 4 days | LeSueur DanielChief Operating Officer | SSale | −5.21K | $4.15 | −$21.6K | −2.4%211.0K after | 10b5-1 |
| Mar 10, 2025 (view filing) | Mar 6 | 4 days | Landry BenjaminGeneral Counsel | SSale | −13.8K | $4.55 | −$62.9K | −7.9%160.4K after | 10b5-1 |
| Mar 10, 2025 (view filing) | Mar 5 | 5 daysLate | LeSueur DanielChief Operating Officer | SSale | −16.9K | $4.52 | −$76.4K | −7.2%216.3K after | 10b5-1 |
| Feb 20, 2025 (view filing) | Feb 18 | 2 days | Llewelyn LindaChief People Officer | SSale | −6.44K | $5.43 | −$35.0K | −7.0%85.8K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 128 holdersThe largest institutional positions in Health Catalyst, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 12,810,861 | $25.5M | 1.55% | −67,839−0.5% | Reduced |
| CDC Financial, Inc. | 7,092,698 | $14.1M | 10.84% | +785,644+12.5% | Added |
| Palogic Value Management, L.P. | 4,922,442 | $9.80M | 3.47% | +2,025,842+69.9% | Added |
| Impax Asset Management Group plc | 4,000,000 | $7.96M | 0.05% | +1,250,000+45.5% | Added |
| Nepsis, Inc. | 2,976,187 | $5.92M | 2.01% | +1,099,898+58.6% | Added |
| Vanguard Capital Management LLC | 2,971,598 | $5.91M | 0.00% | +85,945+3.0% | Added |
| BlackRock, Inc. | 1,836,373 | $3.65M | 0.00% | −3,301,649−64.3% | Reduced |
| Jane Street Group, LLC | 1,037,782 | $2.07M | 0.00% | +1,011,214+3,806.1% | Added |
| Dimensional Fund Advisors LP | 911,819 | $1.81M | 0.00% | −323,051−26.2% | Reduced |
| Geode Capital Management, LLC | 891,357 | $1.77M | 0.00% | −610,076−40.6% | Reduced |
Holders of 5% or more of HCAT
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Health Catalyst, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| First Light Asset Management, LLC | 13D/A | 18.30%13.5M shares | −1.38 ppfrom 19.68% | Nov 14, 20246 filings | Mar 13, 2026 | SEC |
| Stoney Lonesome HF LP | 13G/A | 9.60%7.10M shares | +1.00 ppfrom 8.60% | Dec 22, 20253 filings | Aug 14, 2026 | SEC |
| Palogic Value Management, L.P. | 13D/A | 7.10%5.37M shares | +0.40 ppfrom 6.70% | Jun 22, 20262 filings | Sep 8, 2026 | SEC |
| Impax Asset Management Group plc | 13G | 5.40%4.00M shares | New | Jul 21, 20261 filing | Jul 21, 2026 | SEC |